His devastating diagnosis came after a routine eye examination and subsequent investigations.
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Background: Optic neuritis (ON) is a common cause of visual loss in adults. It is commonly related to or occurs in the scenario of a demyelinating disease. Although treatment leads to visual recovery, ...
Please provide your email address to receive an email when new articles are posted on . Become familiar with antibody-mediated myelin oligodendrocyte glycoprotein and neuromyelitis optica spectrum ...
OPTIC NEURITIS is a painful inflammatory condition affecting the optic nerve, often leading to sudden vision loss, diminished colour perception, and discomfort during eye movement. Although it is ...
Privosegtor ACUITY Trial showed Improved LCVA and preservation of Ganglion Cells in Acute Optic Neuritis. Results from a Multicenter Randomized Placebo-Controlled Double-Masked Trial ZUG, Switzerland, ...
Objective: An early and accurate diagnosis of myelin oligodendrocyte glycoprotein antibody seropositive optic neuritis (MOG-ON) versus seronegative-ON is critical for optimal management. We aimed to ...
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 ...